Naiki K - Search Results

1

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis.

Watanabe K, Uchida Y, Sugawara K, Naiki K, Inao M, Nakayama N, Mochida S. Watanabe K, et al. Among authors: naiki k. J Gastroenterol. 2017 Jul;52(7):830-837. doi: 10.1007/s00535-016-1287-9. Epub 2016 Nov 17. J Gastroenterol. 2017. PMID: 27858246

2

Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis.

Inao M, Mochida S, Matsui A, Eguchi Y, Yulutuz Y, Wang Y, Naiki K, Kakinuma T, Fujimori K, Nagoshi S, Fujiwara K. Inao M, et al. Among authors: naiki k. J Hepatol. 2004 Oct;41(4):584-91. doi: 10.1016/j.jhep.2004.06.033. J Hepatol. 2004. PMID: 15464238

3

Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient.

Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Nakayama N, Mochida S. Uchida Y, et al. Among authors: naiki k. Hepatol Res. 2014 Oct;44(11):1130-1141. doi: 10.1111/hepr.12238. Epub 2013 Oct 25. Hepatol Res. 2014. PMID: 24020990

4

A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors.

Uchida Y, Kouyama J, Naiki K, Mochida S. Uchida Y, et al. Among authors: naiki k. PLoS One. 2014 Nov 14;9(11):e112647. doi: 10.1371/journal.pone.0112647. eCollection 2014. PLoS One. 2014. PMID: 25397971 Free PMC article.

5

SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV.

Hamaoka K, Nagoshi S, Sugawara K, Naiki K, Uchida Y, Inao M, Nakayama N, Fujiwara K, Mochida S. Hamaoka K, et al. Among authors: naiki k. Hepatol Int. 2013 Jun;7(2):683-92. doi: 10.1007/s12072-012-9404-1. Epub 2012 Oct 6. Hepatol Int. 2013. PMID: 26201802

6

Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing.

Uchida Y, Kouyama J, Naiki K, Sugawara K, Ando S, Nakao M, Motoya D, Inao M, Imai Y, Nakayama N, Mochida S. Uchida Y, et al. Among authors: naiki k. J Gastroenterol. 2016 Mar;51(3):260-70. doi: 10.1007/s00535-015-1106-8. Epub 2015 Aug 6. J Gastroenterol. 2016. PMID: 26245700

7

Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.

Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Imai Y, Nakayama N, Mochida S. Uchida Y, et al. Among authors: naiki k. Hepatol Res. 2016 Nov;46(12):1234-1246. doi: 10.1111/hepr.12673. Epub 2016 Mar 30. Hepatol Res. 2016. PMID: 26878268

8

"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.

Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Imai Y, Nakayama N, Mochida S. Uchida Y, et al. Among authors: naiki k. Hepatol Res. 2017 Dec;47(13):1397-1407. doi: 10.1111/hepr.12882. Epub 2017 Apr 19. Hepatol Res. 2017. PMID: 28239934

9

Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.

Kurata H, Uchida Y, Kouyama JI, Naiki K, Nakazawa M, Ando S, Nakao M, Motoya D, Sugawara K, Inao M, Imai Y, Nakayama N, Tomiya T, Mochida S. Kurata H, et al. Among authors: naiki k. Hepatol Res. 2018 Feb;48(3):E372-E378. doi: 10.1111/hepr.12977. Epub 2017 Sep 25. Hepatol Res. 2018. PMID: 28872737

10

Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.

Uemura H, Uchida Y, Kouyama JI, Naiki K, Yamaba S, Fuchigami A, Saito Y, Shiokawa K, Fujii Y, Uchiya H, Nakazawa M, Ando S, Nakao M, Motoya D, Sugawara K, Inao M, Imai Y, Nakayama N, Tomiya T, Mochida S. Uemura H, et al. Among authors: naiki k. Hepatol Res. 2018 Mar;48(4):233-243. doi: 10.1111/hepr.12980. Epub 2017 Oct 20. Hepatol Res. 2018. PMID: 28884930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters